ALK and non-small cell lung carcinoma: In a previous retrospective analysis of paired CSF and plasma samples from 11 patients with ALK-rearranged NSCLC, the CSF-based approach detected both targetable alterations and resistance mechanisms with a higher sensitivity compared to the plasma testing [5].